Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease
Tongtong Liu, Shiming Chen, Jiyu Du, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113973-113973
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 35
Research progress on the synthesis and pharmacology of 1,3,4-oxadiazole and 1,2,4-oxadiazole derivatives: a mini review
Jingjing Wang, Wen Sun, Wei-Dong Jia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2304-2319
Open Access | Times Cited: 49
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Synthesis, Formation Mechanisms, and Molecular Dynamics Simulation of Novel Benzothiazole and Benzo[1,4]oxazin-3(4H)-one as Potential Acetylcholinesterase Inhibitors
D. Nguyen, Dat Van Nguyen, Hue Van Nguyen, et al.
ACS Omega (2025)
Open Access
Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer's disease
Şevval Karaca, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.
RSC Advances (2022) Vol. 12, Iss. 36, pp. 23626-23636
Open Access | Times Cited: 25
Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles
Sergey V. Baykov, Антон А. Шетнев, Artem V. Semenov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5406-5406
Open Access | Times Cited: 13
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Yuxing Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115120-115120
Closed Access | Times Cited: 10
Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease
Xin Lü, Yueqing Li, Qianwen Guan, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 6, pp. 1135-1156
Closed Access | Times Cited: 3
Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents
Mohammed Salah Ayoup, Mohamed Reda Barakat, Hamida Abdel‐Hamid, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 2080-2097
Closed Access | Times Cited: 3
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy
Honghua Zhang, Yan Peng, Linsheng Zhuo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114695-114695
Closed Access | Times Cited: 15
Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease
Jucheng Xia, Shuanghong Dong, Lili Yang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106980-106980
Closed Access | Times Cited: 8
Discovery of novel deoxyvasicinone derivatives with benzenesulfonamide substituents as multifunctional agents against Alzheimer's disease
Shuanghong Dong, Jucheng Xia, Fang Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116013-116013
Closed Access | Times Cited: 8
New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation
Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel‐Hamid, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer’s disease
Dirong Wu, Jiao Chen, Keke Luo, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105760-105760
Closed Access | Times Cited: 13
Customized fluorescent probe for peering into the expression of butyrylcholinesterase in thyroid cancer
W.P. Kang, Mo Ma, Lanlan Xu, et al.
Analytica Chimica Acta (2023) Vol. 1282, pp. 341932-341932
Closed Access | Times Cited: 6
Novel quinoline-based derivatives: A new class of PDE4B inhibitors for adjuvant-induced arthritis
Siqi Xing, Weizheng Fan, Junhua Chen, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114497-114497
Closed Access | Times Cited: 10
Design, synthesis and biological evaluation of new multi-target scutellarein hybrids for treatment of Alzheimer’s disease
Keke Luo, Jiao Chen, Hui Li, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106596-106596
Closed Access | Times Cited: 5
The Different Molecular Targets and Its Significant Role in Alzheimer’s Disease: A Review
Chella Perumal Palanisamy, Manimekalai Pichaivel
Asian Journal of Medicine and Biomedicine (2024) Vol. 8, Iss. 1, pp. 111-143
Open Access | Times Cited: 1
Discovery of novel CXCR4 inhibitors for the treatment of inflammation by virtual screening and biological evaluation
Fang Wang, Jie Ma, Lili Yang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116605-116605
Closed Access | Times Cited: 1
Alkaloids from Fritillaria przewalskii Bulbs and Their Anti‐Alzheimer's Disease Activities
Ruixue Ma, Shu‐Li Zhang, Fengke Lin, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 3
Closed Access
Design, synthesis, anti-trypsin and anti-inflammatory evaluation of new guanidinobenzoic acid ester derivatives
Xiaoyang Hua, Fa-Qi Wang, Zhongjin Yang, et al.
Synthetic Communications (2024) Vol. 54, Iss. 23, pp. 2052-2063
Closed Access
Discovery of novel thiosemicarbazone-acridine targeting butyrylcholinesterase with antioxidant, metal complexing and neuroprotector abilities as potential treatment of Alzheimer's disease: in vitro, in vivo, and in silico studies.
Gleyton Leonel Silva Sousa, Nathália Fonseca Nadur, Larissa A. Ferreira, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117030-117030
Closed Access
Design, Synthesis and Biological Evaluation of Structurally Novel Genipin Derivatives as a Class of Multifunctional Agents for the Treatment of Alzheimer's Disease
Mengdie Sha, Wenxue Xu, Hongyan Cheng, et al.
Research Square (Research Square) (2024)
Open Access
A Computational Approach: Predicting iNOS Inhibition of Compounds for Alzheimer's Disease Treatment Through QSAR Modeling
S. Ahmed, Gulcin Tugcu, Meriç Köksal
ChemistrySelect (2024) Vol. 9, Iss. 44
Closed Access
Alzheimer’s Disease: Treatment of Multi-Factorial Disorders with Multi- Target Approach
Palwinder Singh, Baljit Kaur, Vivesh
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 4, pp. 380-398
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top